Quidel Corporation (QDEL) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Total Assets Chart for Quidel Corporation
Quidel Corporation (QDEL) total assets for FY2025 were USD 5.8B, a -10.2% change from FY2024. Quidel Corporation's total assets grew from USD 17.5M in 1985 to USD 5.8B in 2025 (32867.4% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 25.3%, 10-year CAGR of 30.4%, 20-year CAGR of 21.7%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $941.54M
- Implied Share Price
- $13.73
- Enterprise Value
- $3.70B
- Revenue (TTM)
- $2.67B
- EBITDA
- $484.60M
- Profit Margin
- -39.20%
- Trailing P/E
- —
- Forward P/E
- 9.59
- Price/Book (MRQ)
- 0.42
- Price/Sales (TTM)
- 0.35
- EV/EBITDA
- 22.78
- EV/Revenue
- 1.38
- Dividend Yield
- —
- Book Value
- $25.99
- Free Cash Flow (FY2025)
- -$83.00M
- Free Cash Flow Yield
- -8.82%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.